EFFICACY OF OPICAPONE VERSUS ENTACAPONE IN CATECHOL-O-METHYLTRANSFERASE INHIBITOR-NAIVE PARKINSON'S DISEASE PATIENTS RECENTLY DIAGNOSED WITH MOTOR FLUCTUATIONS: A POST-HOC CONSERVATIVE ANALYSIS

被引：0
|
作者：
Ferreira, J. J. [1 ]
Lees, A. [2 ]
Ebersbach, G. [3 ]
Santos, A. [4 ]
Magalhaes, D. [5 ,6 ]
Rocha, J. -F.
Soares-da-Silva, P. [4 ,5 ,6 ,7 ]
机构：
[1] Univ Lisbon, Lab Clin Pharmacol & Therapeut, Fac Med, Lisbon, Portugal
[2] Natl Hosp Neurol & Neurosurg, Dept Clin & Movement Neurosci, London, England
[3] Beelitz Hosp, Movement Disorders Clin, Beelitz, Germany
[4] BIAL Portela & Ca SA, Dept Res & Dev, Coronado, Portugal
[5] BIAL Portela & Ca SA, Med Affairs Dept, Coronado, Portugal
[6] Univ Porto, Porto, Portugal
[7] Univ Porto, MedInUP Ctr Drug Discovery & Innovat Med, Porto, Portugal
来源：
PARKINSONISM & RELATED DISORDERS | 2020年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
A 210
引用
收藏
页码：E61 / E61
页数：1
相关论文
共 50 条
  • [1] Efficacy of opicapone compared to entacapone in catechol-O-methyltransferase inhibitor-naive Parkinson's disease patients recently diagnosed with motor fluctuations: A post-hoc conservative analysis
    Ferreira, J.
    Lees, A.
    Ebersbach, G.
    Santos, A. -T.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S447 - S447
  • [2] Efficacy and safety/tolerability of opicapone in catechol-O-methyltransferase inhibitor-naive Parkinson's disease patients recently diagnosed with motor fluctuations
    Lees, A.
    Ferreira, J.
    Poewe, W.
    Gama, H.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S461 - S462
  • [3] EFFICACY AND SAFETY/TOLERABILITY OF OPICAPONE IN CATECHOL-O-METHYLTRANSFERASE INHIBITOR-NAIVE PARKINSON'S DISEASE PATIENTS RECENTLY DIAGNOSED WITH MOTOR FLUCTUATIONS
    Lees, A.
    Ferreira, J. J.
    Poewe, W.
    Gama, H.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-da-Silva, P.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E57 - E57
  • [4] Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease
    Ferreira, J. J.
    Rocha, J. -F.
    Falcao, A.
    Santos, A.
    Pinto, R.
    Nunes, T.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (05) : 815 - E56
  • [5] Entacapone:: A catechol-O-methyltransferase inhibitor for the adjunctive treatment of Parkinson's disease
    Najib, J
    CLINICAL THERAPEUTICS, 2001, 23 (06) : 802 - 832
  • [6] Thermal behavior of entacapone, a catechol-O-methyltransferase inhibitor used in Parkinson’s disease
    Titus Vlase
    Paul Albu
    Adriana Ledeţi
    Denisa Circioban
    Mădălina Mateescu
    Codruţa Moşoiu
    Gabriela Vlase
    Journal of Thermal Analysis and Calorimetry, 2018, 134 : 711 - 720
  • [7] Thermal behavior of entacapone, a catechol-O-methyltransferase inhibitor used in Parkinson's disease
    Vlase, Titus
    Albu, Paul
    Ledeti, Adriana
    Circioban, Denisa
    Mateescu, Madalina
    Mosoiu, Codruta
    Vlase, Gabriela
    JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2018, 134 (01) : 711 - 720
  • [8] Efficacy and safety of opicapone in Parkinson's disease patients according to duration of motor fluctuations: post-hoc analysis of BIPARK-I and II
    Ebersbach, G.
    Rascol, O.
    Ferreira, J. J.
    Costa, R.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 659 - 660
  • [9] Efficacy and Safety of Opicapone in Parkinson's Disease Patients According to Duration of Motor Fluctuations: Post-Hoc Analysis of BIPARK-I and II
    Ebersbach, G.
    Rascol, O.
    Ferreira, J.
    Costa, R.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S444 - S444
  • [10] EFFICACY/SAFETY OF OPICAPONE IN PARKINSON'S DISEASE PATIENTS ACCORDING TO DURATION OF MOTOR FLUCTUATIONS: POST-HOC ANALYSIS OF BIPARK-I AND II
    Ebersbach, G.
    Rascol, O.
    Ferreira, J. J.
    Costa, R.
    Rocha, J. F.
    Magalhaes, D.
    Soares-da-Silva, P.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E63 - E64
12345